Quantitative chest X-ray radiomics for therapy response monitoring in patients with pulmonary tuberculosis

Show simple item record

dc.contributor.author Du Plessis, Tamarisk
dc.contributor.author Rae, William Ian Duncombe
dc.contributor.author Ramkilawon, Gopika
dc.contributor.author Ramkilawon, Gopika Devi
dc.contributor.author Martinson, Neil Alexander
dc.contributor.author Sathekge, Mike Machaba
dc.date.accessioned 2024-05-15T12:16:40Z
dc.date.available 2024-05-15T12:16:40Z
dc.date.issued 2023-09-01
dc.description DATA AVAILABILITY STATEMENT : Data are available on request from the corresponding author. en_US
dc.description.abstract Tuberculosis (TB) remains the second leading cause of death globally from a single infectious agent, and there is a critical need to develop improved imaging biomarkers and aid rapid assessments of responses to therapy. We aimed to utilize radiomics, a rapidly developing image analysis tool, to develop a scoring system for this purpose. A chest X-ray radiomics score (RadScore) was developed by implementing a unique segmentation method, followed by feature extraction and parameter map construction. Signature parameter maps that showed a high correlation to lung pathology were consolidated into four frequency bins to obtain the RadScore. A clinical score (TBscore) and a radiological score (RLscore) were also developed based on existing scoring algorithms. The correlation between the change in the three scores, calculated from serial X-rays taken while patients received TB therapy, was evaluated using Spearman’s correlation. Poor correlations were observed between the changes in the TBscore and the RLscore (0.09 (p-value = 0.36)) and the TBscore and the RadScore (0.02 (p-value = 0.86)). The changes in the RLscore and the RadScore had a much stronger correlation of 0.22, which is statistically significant (p-value = 0.02). This shows that the developed RadScore has the potential to be a quantitative monitoring tool for responses to therapy. en_US
dc.description.department Nuclear Medicine en_US
dc.description.department Statistics en_US
dc.description.librarian am2024 en_US
dc.description.sdg SDG-03:Good heatlh and well-being en_US
dc.description.sponsorship FUNDING : The APC was funded by the Department of Nuclear Medicine, University of Pretoria, South Africa. en_US
dc.description.uri https://www.mdpi.com/journal/diagnostics en_US
dc.identifier.citation Du Plessis, T.; Rae, W.I.D.; Ramkilawon, G.; Martinson, N.A.; Sathekge, M.M. Quantitative Chest X-ray Radiomics for Therapy Response Monitoring in Patients with Pulmonary Tuberculosis. Diagnostics 2023, 13, 2842. https://DOI.org/10.3390/diagnostics13172842. en_US
dc.identifier.issn 2075-4418 (online)
dc.identifier.other 10.3390/diagnostics13172842
dc.identifier.uri http://hdl.handle.net/2263/95995
dc.language.iso en en_US
dc.publisher MDPI en_US
dc.rights © 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license. en_US
dc.subject Radiomics en_US
dc.subject Segmentation en_US
dc.subject Feature extraction en_US
dc.subject Chest X-rays en_US
dc.subject Radiomics score en_US
dc.subject Tuberculosis (TB) en_US
dc.subject SDG-03: Good health and well-being en_US
dc.title Quantitative chest X-ray radiomics for therapy response monitoring in patients with pulmonary tuberculosis en_US
dc.type Article en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record